CWA to Testify at FDA Hearing on Abortion Drug

Washington, D.C. – A Food and Drug Administration (FDA) Advisory Committee will meet on Thursday, June 17, to discuss if Ella, a drug that is similar to the abortion drug RU-486, should be available in the U.S. Ella blocks the hormone progesterone, interfering with the lining of the uterus so an embryo cannot implant or, […]